US 12121524
DNA-PK inhibitors
granted A61KA61K31/4245A61K31/498
Quick answer
US patent 12121524 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/4245, A61K31/498, A61K31/501, A61K31/506